Cidara Therapeutics, Inc. — Director's Dealing 2021

Jun 25, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cidara Therapeutics, Inc. (CDTX)
CIK: 0001610618
Period of Report: 2021-06-23

Reporting Person: Gollaher David L (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-23	Stock Option (right to buy)	$1.92	A	17500	Acquired	2031-06-22	Common Stock (17500.0)	Direct

Footnotes

F1: The shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant or (ii) the day prior to the date of the Issuer's 2022 annual meeting of stockholders.